secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-01-29T23:59:59+00:00
Accession:  0001493152-25-004180
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions adds Quantum TM, expanding fingerprint drug testing to 10 UK sites
--------------------------------------------------------------------------------

- Quantum Traffic Management adopts INBS fingerprint drug screening across 10 UK sites, replacing saliva/urine methods.
- INBS now serves over 400 accounts across 19 countries; plans US market entry in 2025.
- INBS filed FDA 510(k) submission in December 2024 for US clearance.
- Quantum TM's managing director highlights improved efficiency with in-house rapid testing.
- Serves industries including construction, manufacturing, transport, and logistics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225004180/0001493152-25-004180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225004180/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-004180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer